세계의 광학 유전체 매핑 시장 보고서(2025년)
Optical Genome Mapping Global Market Report 2025
상품코드 : 1825845
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

광학 유전체 매핑 시장 규모는 향후 몇 년 동안 비약적인 성장이 예상됩니다. 2029년에는 CAGR 27.6%로 6억 달러로 성장할 것입니다. 예측 기간의 성장은 유전체 연구의 발전, 정밀의료에 대한 수요 증가, 정부 자금 및 이니셔티브 증가, 탄탄한 의료 인프라, 유전성 질환 및 암의 유병률 증가에 기인합니다. 예측 기간의 주요 동향으로는 고급 OGM 서비스, 유전체 연구 이니셔티브, DNA 매핑 기술 발전, 기술 발전, 유전체 데이터 처리를 위한 AI 및 ML과 같은 데이터 분석 기술의 발전 등이 있습니다.

향후 5년간 27.6%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 프랑스와 싱가포르에서 수입되는 고해상도 유전체 매핑 시스템 및 나노 채널 어레이 칩의 비용을 상승시킴으로써 미국의 유전자 연구에 혼란을 초래할 수 있으며, 정밀 의료 기술의 채택을 지연시키고 연구기관의 오버헤드를 상승시킬 수 있음. 증가시킬 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

정밀의료에 대한 수요 증가는 향후 광학 유전체 매핑 시장의 확대를 견인할 것으로 예상됩니다. 유전, 생활습관, 환경 등 개인의 특성에 따라 치료 및 예방 조치를 하는 정밀의료는 만성질환의 유병률 증가, 유전체 기술의 발전, 투자 및 자금의 증가, 맞춤형 의료에 대한 환자 선호도 증가 등의 요인에 의해 촉진되고 있습니다. 광학 유전체 매핑은 다양한 질병과 관련된 유전체 변화에 대한 포괄적이고 정확한 인사이트를 제공함으로써 정밀 의료를 추진하는 데 있어 매우 중요한 역할을 하고 있습니다. 예를 들어, 2024년 2월 Personalized Medicine Coalition이 보고한 희귀질환에 대한 FDA 승인 건수는 2022년 6건이었던 반면, 2023년에는 16건으로 증가하여 정밀의료에 대한 수요 증가와 광학유전체매핑 시장의 성장의 상관관계를 강조하고 있습니다. 정밀의료에 대한 수요 증가와 광학 유전체 매핑 시장의 성장과의 상관관계를 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Optical genome mapping (OGM) represents an innovative genomic analysis technique focused on generating high-resolution, extensive maps of Deoxyribonucleic Acid (DNA) molecules to discern structural variations and genome architecture. This cutting-edge technology employs optical methods to visualize and analyze extended DNA strands, facilitating the detection of large-scale structural variations such as insertions, deletions, duplications, inversions, and translocations, which may pose challenges for traditional sequencing methods.

The primary products within the optical genome mapping market include instruments, consumables and reagents, software, and services. Instruments encompass the hardware and machinery essential for visualizing and analyzing large DNA molecules. They find applications across various fields, including structural variant detection, genome assembly, microbial strain typing, and others, utilized by biotechnology and pharmaceutical companies, clinical laboratories, academic research institutes, and other relevant stakeholders.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The optical genome mapping market research report is one of a series of new reports from The Business Research Company that provides optical genome mapping market statistics, including the optical genome mapping industry global market size, regional shares, competitors with optical genome mapping market share, detailed optical genome mapping market segments, market trends, and opportunities, and any further data you may need to thrive in the optical genome mapping industry. These optical genome mapping market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The optical genome mapping market size has grown exponentially in recent years. It will grow from $0.17 billion in 2024 to $0.23 billion in 2025 at a compound annual growth rate (CAGR) of 29.3%. The growth in the historic period can be attributed to increasing demand for advanced genomic analysis tools and techniques, increasing research on large-scale genome identification, increasing number of collaborations between instrument manufacturers and hospitals, adoption of optical genome mapping in research institutions and pharmaceutical companies and cost-effectiveness and efficiency lead to rapid analysis of large genomes with high accuracy.

The optical genome mapping market size is expected to see exponential growth in the next few years. It will grow to $0.6 billion in 2029 at a compound annual growth rate (CAGR) of 27.6%. The growth in the forecast period can be attributed to advancements in genomic research, increasing demand for precision medicine, rising government funding and initiatives, robust healthcare infrastructure, and increasing prevalence of genetic diseases and cancer. Major trends in the forecast period include advanced OGM services, genomic research initiatives, advancements in DNA mapping technologies, technological advancements, and advancements in data analysis technologies such as AI and ML for genomic data processing.

The forecast of 27.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. genetic research by increasing costs for high-resolution genome mapping systems and nanochannel array chips imported from France and Singapore, potentially leading to slower adoption of precision medicine technologies and higher research institution overheads. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for precision medicine is anticipated to drive the expansion of the optical genome mapping market in the future. Precision medicine, which tailors medical treatments and preventive measures to individual characteristics such as genetics, lifestyle, and environment, is fueled by factors such as the increasing prevalence of chronic diseases, advancements in genomic technologies, augmented investment and funding, and heightened patient preference for personalized care. Optical genome mapping plays a pivotal role in advancing precision medicine by providing comprehensive and precise insights into genomic alterations associated with various diseases. For example, the FDA's approval of 16 novel personalized therapies for rare diseases in 2023, compared to six in 2022, as reported by the Personalized Medicine Coalition in February 2024, underscores the escalating demand for precision medicine and its correlation with the growth of the optical genome mapping market.

Leading companies in the optical genome mapping market are focusing on the development of optical genome mapping-based laboratory-developed tests (LDTs) to bolster diagnostic capabilities and furnish more precise genomic information. These LDTs are diagnostic assays crafted and implemented within individual clinical laboratories utilizing optical genome mapping (OGM) technology. For instance, Bionano Genomics Inc., a US-based provider of genome analysis software, unveiled an optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD) in September 2022. This offering enables Bionano Laboratories to provide services to clients seeking to integrate OGM into their diagnostic routines and research endeavors, collaborating with hospitals, pharmaceutical firms, and other stakeholders.

In October 2022, Bionano Genomics Inc. augmented its capabilities in optical genome mapping (OGM) by acquiring BioDiscovery Inc. for $100 million. This strategic acquisition integrates BioDiscovery's NxClinical software, a leading platform-agnostic solution that amalgamates next-generation sequencing (NGS) and microarray data for comprehensive variant analysis, bolstering Bionano's proficiency in OGM. BioDiscovery Inc., a US-based biotechnology company specializing in software solutions for genomic data analysis and visualization, enhances Bionano's position in the optical genome mapping market.

Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

North America was the largest region in the optical genome mapping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the optical genome mapping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The optical genome mapping market includes revenues earned by entities by providing services such as structural variation detection, genome assembly, microbial strain typing, clinical diagnostics, cancer genomics bioinformatics, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The optical genome mapping market also includes sales of instruments, consumables and reagents, software, and bioinformatics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Optical Genome Mapping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on optical genome mapping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for optical genome mapping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The optical genome mapping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Optical Genome Mapping Market Characteristics

3. Optical Genome Mapping Market Trends And Strategies

4. Optical Genome Mapping Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Optical Genome Mapping Growth Analysis And Strategic Analysis Framework

6. Optical Genome Mapping Market Segmentation

7. Optical Genome Mapping Market Regional And Country Analysis

8. Asia-Pacific Optical Genome Mapping Market

9. China Optical Genome Mapping Market

10. India Optical Genome Mapping Market

11. Japan Optical Genome Mapping Market

12. Australia Optical Genome Mapping Market

13. Indonesia Optical Genome Mapping Market

14. South Korea Optical Genome Mapping Market

15. Western Europe Optical Genome Mapping Market

16. UK Optical Genome Mapping Market

17. Germany Optical Genome Mapping Market

18. France Optical Genome Mapping Market

19. Italy Optical Genome Mapping Market

20. Spain Optical Genome Mapping Market

21. Eastern Europe Optical Genome Mapping Market

22. Russia Optical Genome Mapping Market

23. North America Optical Genome Mapping Market

24. USA Optical Genome Mapping Market

25. Canada Optical Genome Mapping Market

26. South America Optical Genome Mapping Market

27. Brazil Optical Genome Mapping Market

28. Middle East Optical Genome Mapping Market

29. Africa Optical Genome Mapping Market

30. Optical Genome Mapping Market Competitive Landscape And Company Profiles

31. Optical Genome Mapping Market Other Major And Innovative Companies

32. Global Optical Genome Mapping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Optical Genome Mapping Market

34. Recent Developments In The Optical Genome Mapping Market

35. Optical Genome Mapping Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기